[1]JournaloftheAmericanChemicalSociety,1947,vol.69,p.858
[1]Cha,JinSoon;Brown,HerbertC.[JournalofOrganicChemistry,1993,vol.58,#15,p.3974-3979]
[2]Murugesan,Kathiravan;Senthamarai,Thirusangumurugan;Sohail,Manzar;Alshammari,AhmadS.;Pohl,Marga-Martina;Beller,Matthias;Jagadeesh,RajenahallyV.[ChemicalScience,2018,vol.9,#45,p.8553-8560]
[3]Huisgen;Ruechardt[JustusLiebigsAnnalenderChemie,1956,vol.601,p.21,31]
[4]Benoitetal.[AnnalesPharmaceutiquesFrancaises,1952,vol.10,p.181,186]
[5]Kotschhetkow;Petrutschenko[ZhurnalObshcheiKhimii,1958,vol.28,p.2252,2254,2255;engl.Ausg.S.2288.2289,2290]
[6]Rupe;Gisiger[HelveticaChimicaActa,1925,vol.8,p.349]
[7]Decombe[ComptesRendusHebdomadairesdesSeancesdel'AcademiedesSciences,1946,vol.222,p.90]
[8]Freeman;Ringk;Spoerri[JournaloftheAmericanChemicalSociety,1947,vol.69,p.858]
[9]Nystrom[JournaloftheAmericanChemicalSociety,1955,vol.77,p.2544]
[10]Eiden;Iwan[ArchivderPharmazieundBerichtederDeutschenPharmazeutischenGesellschaft,1970,vol.303,#7,p.612-617]
[11]Rajsner,M.etal.[CollectionofCzechoslovakChemicalCommunications,1963,vol.28,p.1031-1043]
[12]Brown,HerbertC.;Choi,YongMoon;Narasimhan,S.[Synthesis,1981,#8,p.605-606]
[13]Wakamatsu,Takeshi;Inaki,Harumi;Ogawa,Akemi;Watanabe,Masako;Ban,Yoshio[Heterocycles,1980,vol.14,#10,p.1437-1440]
[14]Zamani,Asghar;PoursattarMarjani,Ahmad;Nikoo,Abbas;Heidarpour,Mojtaba;Dehghan,Ahmad[InorganicandNano-MetalChemistry,2018,vol.48,#3,p.176-181]
[15]Mészáros,Rebeka;Peng,Bai-Jing;Ötvös,SándorB.;Yang,Shyh-Chyun;Fülöp,Ferenc[ChemPlusChem,2019,vol.84,#10,p.1508-1511]
[1]Nagubandi,Sreeramulu;Fodor,G.[JournalofHeterocyclicChemistry,1980,vol.17,p.1457-1463]
[2]Kurouchi,Hiroaki[ChemicalCommunications,2020,vol.56,#59,p.8313-8316]
[3]Otsuka,Rikuto;Maruhashi,Kazuo;Ohwada,Tomohiko[Synthesis,2018,vol.50,#10,p.2041-2057]
[4]Rupe;Gisiger[HelveticaChimicaActa,1925,vol.8,p.349]
[5]Levy;Gallais[BulletindelaSocieteChimiquedeFrance,1928,vol.<4>43,p.865]
[6]Nagubandi,Sreeramulu[OrganicMassSpectrometry,1980,vol.15,#10,p.535-538]
[1]Journalofmedicinalchemistry,1989,vol.32,p.1667-1673
[2]JournalofMedicinalChemistry,2000,vol.43,p.4135-4150
[3]Patent:US4582823,1986,A
[4]Patent:US4657897,1987,A
[1]JournalofMedicinalChemistry,1991,vol.34,p.2877-2882
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: Synthesis, structure-affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: structural factors contributing to selectivity.
Journal: Bioorganic & medicinal chemistry 20090915
Title: NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl)piperidine enantiomers and of related compounds.
Journal: Bioorganic & medicinal chemistry 20090501
Title: Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.
Journal: Journal of medicinal chemistry 20081113
Title: Structure-activity correlations for beta-phenethylamines at human trace amine receptor 1.
Journal: Bioorganic & medicinal chemistry 20080801
Title: Two- and three-dimensional quantitative structure-activity relationships studies on a series of liver x receptor ligands.
Journal: The open medicinal chemistry journal 20080101
Title: Quantification of cibenzoline by enzyme-linked immunosorbent assay.
Journal: Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20070601
Title: Geometry-affinity relationships of the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene.
Journal: Journal of medicinal chemistry 20020411
Title: Exploring the relationship between binding modes of 9-(aminomethyl)-9,10-dihydroanthracene and cyproheptadine analogues at the 5-HT2A serotonin receptor.
Journal: Bioorganic & medicinal chemistry letters 20010226
